These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3187409)

  • 1. Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
    Malmström PU; Busch C; Norlen BJ
    Scand J Urol Nephrol Suppl; 1988; 110():205-11. PubMed ID: 3187409
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of blood groups and transitional cell carcinoma of the bladder.
    Kirkali Z; Eryigit M
    Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
    Murshidi MS
    Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of blood group type on prognosis of transitional cell carcinoma of the urinary bladder.
    Malmström U; Busch C; Norlen BJ; Andersson B
    Eur Urol; 1990; 18(2):97-100. PubMed ID: 2226592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma.
    Malmström PU; Busch C; Norlen BJ; Andersson B
    Scand J Urol Nephrol; 1988; 22(4):265-70. PubMed ID: 3238331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood group isoantigen deletion and chromosomal abnormalities in bladder cancer.
    Pauwels RP; Schapers RF; Smeets AW; Jansen LE; Debruyne FM; Geraedts JP
    J Urol; 1988 Nov; 140(5):959-63. PubMed ID: 3050155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of blood groups and bladder cancer.
    Srinivas V; Khan SA; Hoisington S; Varma A; Gonder MJ
    J Urol; 1986 Jan; 135(1):50-2. PubMed ID: 3941468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the urinary bladder. Histologic staging and grading in relation to survival in a surgically treated material.
    Schroeder E; Christensen TB; Jacobsen F; Sjolin KE
    Acta Chir Scand Suppl; 1973; 433():126-31. PubMed ID: 4513502
    [No Abstract]   [Full Text] [Related]  

  • 14. [The study of the ABH isoantigen of bladder tumors].
    Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered cell surface antigen expression in bladder carcinoma detected by a new hemagglutinating monoclonal antibody.
    Rearden A; Nachtsheim DA; Frisman DM; Chiu P; Elmajian DA; Baird SM
    J Immunol; 1983 Dec; 131(6):3073-7. PubMed ID: 6417241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of the blood group antigens A and B in carcinoma of the urinary bladder].
    Tichý M; Jansa P; Student V; Tichá V; Vanák J
    Bratisl Lek Listy; 1992 Aug; 93(8):415-20. PubMed ID: 1464022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of A,B and H blood group antigens in urothelial carcinoma of the urinary bladder].
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Cesk Patol; 1991 Mar; 27(1-2):13-9. PubMed ID: 1893425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of tissue ABH antigens in superficial bladder tumours.
    Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T
    Int Urol Nephrol; 1991; 23(1):37-44. PubMed ID: 1938218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
    Joudi FN
    Eur Urol; 2008 Mar; 53(3):579. PubMed ID: 17804153
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.